Comprehensive care includes support for healthy eating, lifestyle changes, and ongoing progress tracking to help you achieve and maintain your weight loss goals
By addressing multiple risk factors, GLP-1 contributes to holistic wellness improvements beyond merely controlling diabetes
The National Institutes of Health provides resources on recognizing overtraining syndrome and its relationship to inadequate recovery
More recently, GLP-1 RA drugs have been approved for weight loss, cardiovascular disease, and chronic kidney disease
The efficacy and safety of combinations of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of type 2 diabetes or obese adults: a systematic review and meta-analysis
This means weeks of rebuilding to your therapeutic dose, during which your results suffer and you relive the initial side effects all over again